Ogkologos

4396 POSTS 0 COMMENTS

FDA Approves Cosibelimab-ipdl for Metastatic or Locally Advanced Cutaneous Squamous Cell...

Ogkologos - January 31, 2025

A Chemotherapy-Free Regimen of Tucatinib and Trastuzumab Shows Antitumour Activity with...

Ogkologos - January 29, 2025

Understanding Genomic Correlates of Response and Acquired Resistance to FGFR Inhibitors

Ogkologos - January 28, 2025

Efficacy and Safety of Datopotamab Deruxtecan in Patients with Pretreated Advanced/Metastatic...

Ogkologos - January 27, 2025

FDA Grants Accelerated Approval to Encorafenib with Cetuximab and mFOLFOX6 for...

Ogkologos - January 24, 2025

EMA Recommends Extension of Indications for Dostarlimab

Ogkologos - January 23, 2025

Trastuzumab Emtansine Improves OS with Sustained Improvement in iDFS Among Patients...

Ogkologos - January 22, 2025

Manageable Safety and Promising Activity of Neoadjuvant Pembrolizumab plus Vibostolimab, Pembrolizumab...

Ogkologos - January 21, 2025

Dual Antigen Targeting with Talquetamab plus Teclistamab in Patients with Relapsed...

Ogkologos - January 20, 2025

FDA Approves Durvalumab for Limited-Stage Small Cell Lung Cancer

Ogkologos - January 17, 2025

1...596061...440 Page 60 of 440

MOST POPULAR

Cabozantinib Improves PFS in Patients with Previously Treated, Progressive Advanced Extrapancreatic...

October 25, 2024

Strategy May Prevent Tumor Resistance to Targeted Cancer Therapies

March 17, 2023

Man Spent 20 Years Tracking Down And Buying His Late Mother’s...

October 30, 2021

For HPV-Positive Women, Test Can Guide Cervical Cancer Screening Follow-Up

October 11, 2018

FDA Approves Cosibelimab-ipdl for Metastatic or Locally Advanced Cutaneous Squamous Cell...

A Chemotherapy-Free Regimen of Tucatinib and Trastuzumab Shows Antitumour Activity with...

Understanding Genomic Correlates of Response and Acquired Resistance to FGFR Inhibitors

Efficacy and Safety of Datopotamab Deruxtecan in Patients with Pretreated Advanced/Metastatic...

FDA Grants Accelerated Approval to Encorafenib with Cetuximab and mFOLFOX6 for...

EMA Recommends Extension of Indications for Dostarlimab

Trastuzumab Emtansine Improves OS with Sustained Improvement in iDFS Among Patients...

Manageable Safety and Promising Activity of Neoadjuvant Pembrolizumab plus Vibostolimab, Pembrolizumab...

Dual Antigen Targeting with Talquetamab plus Teclistamab in Patients with Relapsed...

FDA Approves Durvalumab for Limited-Stage Small Cell Lung Cancer

MOST POPULAR

Cabozantinib Improves PFS in Patients with Previously Treated, Progressive Advanced Extrapancreatic...

Strategy May Prevent Tumor Resistance to Targeted Cancer Therapies

Man Spent 20 Years Tracking Down And Buying His Late Mother’s...

For HPV-Positive Women, Test Can Guide Cervical Cancer Screening Follow-Up

HOT NEWS

Breast-Cancer Mom Is Living On 84 Pence As She Fights For...

Increase in Node-Positive and Stage III Breast Cancer After Two Months...

It Might Sound Trite But…

ESMO Announces Results of 2025 Elections

POPULAR POSTS

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

POPULAR CATEGORY